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Canine reference intervals for coagulation markers using the STA
SatelliteH and the STA-R EvolutionH analyzers
Anne Geffre´,1 Sophie Grollier, Camille Hanot, Franc¸ois Vergez, Catherine Trumel,
Jean-Pierre Braun
Abstract. The aim of the current study was to determine canine reference intervals for prothrombin time
(PT), activated partial thromboplastin time (APTT), fibrinogen, and antithrombin (AT) according to
international recommendations. The STA SatelliteH coefficients of variation of within-laboratory imprecision
were 3.9%, 1.3%, 6.9%, and 5.1% for PT, APTT, fibrinogen, and AT, respectively. At 4uC, citrated specimens
were stable up to 8 hr for whole blood and 36 hr for plasma, except for APTT, which increased slightly
(,1 sec). Nonparametric reference intervals determined in citrated plasma from 139 healthy fasting purebred
dogs were 6.9–8.8 sec, 13.1–17.2 sec, 1.24–4.30 g/l, and 104–188% for PT, APTT, fibrinogen, and AT,
respectively. Based on Passing–Bablok comparison between STA Satellite and STA-R EvolutionH using 60
frozen specimens from a canine plasma bank, the corresponding reference intervals were transferred to the
STA-R Evolution: 7.1–9.2 sec, 12.9–17.3 sec, 1.20–4.43 g/l, and 94–159% for PT, APTT, fibrinogen, and AT,
respectively.
Key words: Activated partial thromboplastin time; antithrombin; dogs; fibrinogen; prothrombin time;
reference intervals.
Introduction
There are few studies in the veterinary literature on
reference intervals for coagulation markers of dogs,
and most of the studies do not meet international
recommendations such as defined in the International
Federation of Clinical Chemistry and Laboratory
Medicine (IFCC) and the Clinical and Laboratory
Standards Institute (CLSI) guidelines.2 Introduction
of a new analyzer into the laboratory was the
opportunity to make a proper a priori determination
of coagulation test reference values in dogs, which
may be further used for transference in other sites
after proper verification using the new recommenda-
tions.2 The current study was based on the 13-step
procedure recommended by IFCC-CLSI and in-
volved a reference sample representative of the canine
population in France, according to the breed distri-
bution reported by the Socie´te´ Centrale Canine
(http://www.scc.asso.fr/mediatheque/statistiques, ac-
cessed January 2008). The 4 analytes studied were
chosen because they concerned the coagulation tests
most frequently requested at the Central Laboratory
of the clinics of the Ecole Nationale Ve´te´rinaire de
Toulouse (Toulouse, France).
The present study therefore consisted of determin-
ing the reference interval for prothrombin time (PT),
activated partial thromboplastin time (APTT), fibrin-
ogen, and antithrombin (AT) in purebred healthy
dogs with the STA SatelliteH analyzera according to
international recommendations. The reference inter-
vals thus determined were transferred to another
laboratory in the same city, using the same reagents
but a different analyzer, namely, the STA-R Evolu-
tionH analyzer.a
Material and methods
The current study was performed between October 2007
and March 2008. Before each run of analyses, the STA
Satellite analyzer was checked according to the manufac-
turer’s recommendations.a Analyses were performed by
coagulometric method for PT, APTT, and fibrinogen, and
by a colorimetric test for AT. Reagents and characteristics
of the techniques are summarized in Table 1. Where
necessary, a veterinary configuration of the analyzer’s
software performed automatic dilutions, thereby increasing
the standard human analytical ranges for the lowest and
highest values.
As canine control solutions are not available for
coagulation testing, the accuracy and imprecision of the
STA Satellite analyzer were assessed with 2 human control
solutions (STA Coag Control N + P)a according to the
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CLSI (formerly NCCLS).11 Duplicate measurements of
each control solution were done in the morning and
afternoon for 5 consecutive days. Repeatability in canine
plasma was evaluated from the duplicate results obtained
for each analysis.
All canine specimens were collected from the jugular vein
of overnight-fasted dogs into a 1.8-ml 3.8% Na3 citrate
vacuum tube with a 0.8 mm 3 40 mm needle.b The
specimens were gently inverted 10 times, identified, and
then stored at 4uC until centrifugation for 15 min at 1,300
3 g.c Because of the distance of certain breeding locations,
the maximum time before centrifugation and subsequent
analyses was 7.5 hr, with most analyses being performed
within 4 hr of sampling. Reference intervals were deter-
mined in a reference sample group composed of 139 dogs
selected according to the following inclusion criteria: 1)
purebred dogs (registered in the Livre des Origines
Franc¸ais) directly sampled at the breeder’s kennel, 2)
healthy animals (questionnaire and physical examination),
and 3) dogs fasted overnight.
The proportions of the different breeds in the sample
group were as representative as possible of the proportions
of the breeds in the French canine population. When more
than 5 dogs had to be sampled in a single breed, they were
taken from at least 2 different owners. Exclusion criteria
were incorrect sampling or filling of the tube, abnormal
color of plasma, any reported illness in the month
preceding sampling, abnormal bleeding, any treatment
(except external antiparasitic), and nonfasted dogs.
Normality of distributions was tested by Anderson–
Darling test, and reference intervals were determined by the
nonparametric method according to IFCC-CLSI recom-
mendations,2 which is based on the ranking of the 2.5 and
97.5 percentiles. Because part of the present study required
sample transport from the dog breeding establishments to
the laboratory, stability of the analytes had to be tested in a
preliminary study. Aliquots of 6 citrated canine whole
blood specimens were analyzed by taking duplicate
measurements within 1 hr of sampling, and after storage
of whole blood for 4 hr and 8 hr at 4uC. Centrifugation was
performed just before each run of analyses. Aliquots of 6
citrated canine plasma specimens were also analyzed by
taking duplicate measurements within 1 hr of sampling,
and then after storage for 12, 24, and 36 hr at 4uC.
Transference of the reference intervals was based on a
procedure of method comparison5,10 using 60 canine
specimens obtained from the plasma bank of the Central
Laboratory. All calculations were performed with an Excel
spreadsheet, a statistical analysis software,d and the free-
ware Reference Value Advisor (http://www.biostat.envt.fr/
spip/spip.php?article63) for the determination of reference
intervals.
Results
The within-laboratory imprecision and repeatabil-
ity coefficients of variation (CVs) of the STA Satellite
in the laboratory were similar or slightly higher than
the manufacturer’s indications. Bias was low except
for PT in the ‘‘P’’ control solution and for fibrinogen
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(up to 10.8% bias; Table 1). There was no statistically
significant change of the analytes in whole blood
stored up to 8 hr and in plasma stored up to 36 hr at
4uC (Wilcoxon test, with Bonferroni correction for
multiple comparisons, P . 0.05), except for APPT,
which was slightly (,1 sec) but significantly increased
in whole blood at the eighth hour and in plasma at the
36th hour (Wilcoxon test, P 5 0.03).
The main breeds of dog were Brittany (14),
German Shepherd Dog (12), Labrador Retriever
(10), Belgian Malinois (10), Yorkshire Terrier (9),
Rottweiler (9), French Bulldog (9), and Australian
Shepherd (9). There were 88 females, 2 spayed
females, and 49 males. Ages ranged from 1 to 14 years
(Fig. 1). The distributions of the 4 analytes in the
reference sample group are presented in Figure 2.
There was no outlier according to the Dixon–Reed
criterion.14 The AT distribution was not significantly
different from Gaussian. All other distributions could
be transformed into Gaussian, except for PT, which
remained significantly different after all transforma-
tions tested. The best fit for PT was obtained by Box–
Cox transformation (Anderson–Darling test, P 5
0.014). Descriptive statistics with the corresponding
reference intervals are summarized in Table 2. The
nonparametric reference intervals thus determined
were 6.9–9.0 sec, 13.1–17.7 sec, 1.24–4.62 g/l, and
104–188% for PT, APTT, fibrinogen, and AT,
respectively. Partitioning according to sex was not
relevant according to Harris–Boyd criterion,4 even
though the AT values were significantly lower in
males than in females (Student’s t-test after checking
for homogeneity of variances, P 5 0.002) with means
of 136% and 147%, respectively. There were not
enough values in each subgroup to make partitions
according to age or breed.
For transference of the reference intervals to the
STA-R Evolution analyzer, the results of some
comparison analyses could not be obtained for
technical reasons, so comparison was based on at
least 53 paired analyses (Table 3). For AT, there was
good correlation but a combined bias, with the results
by STA-R Evolution being approximately 12% lower
than with STA Satellite. Passing–Bablok equations
were applied to the previously determined reference
intervals to transfer reference intervals for the STA-R
Evolution (i.e., 7.1–9.2 sec for PT, 12.9–17.3 sec for
Figure 1. Distribution of ages of the 139 dogs used in the
study of reference values of coagulation tests.
Figure 2. Histograms of prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and antithrombin
(AT) in 139 healthy dogs (black curve: Gaussian curve; vertical lines: reference limits with 90% confidence intervals).
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APTT, 1.20–4.43 g/l for fibrinogen, and 94–159% for
AT).
Discussion
The pre-analytical conditions were chosen accord-
ing to recommendations for coagulation testing in
human clinical pathology.1,13 These conditions are
routinely used in veterinary clinical pathology;
although, to the authors’ knowledge, they have never
been validated except for absence of a significant
effect of citrate concentration between 3.2% and
3.8%,8 lack of effect of sampling by direct venipunc-
ture or through a catheter,7 significant effect of
abnormal colors of plasmas,9 and of dehydration.12
Prothrombin time, APTT, and fibrinogen are
almost unchanged in canine plasma stored for up to
2 days at room temperature or at 4uC,3 which is
longer than the delays recommended for human
specimens.1 The durations of storage tested in the
current study were chosen according to the actual
conditions of the experiment where blood specimens
collected at the individual breeders’ locations usually
arrived at the laboratory after less than 4 hr and, in a
very few cases, after up to 7.5 hr. According to the
results of the stability study, PT, fibrinogen, and AT
would not have been altered even after 7.5 hr, but a
moderate increase of APTT might have occurred. The
latter change did not exceed the 90% confidence
intervals of the reference limits, thus it should have no
clinical relevance, which is the reason why the results
were included in the study. Finally, the testing of
plasma storage up to 36 hr was unnecessary: this had
been done in case analyses needed to be postponed
because of a technical difficulty.
Selecting the reference sample group according to
‘‘well-defined criteria’’ is the most difficult task when
establishing reference intervals. The aim of selection is
to make the reference individuals ‘‘as comparable to
the patients as possible, except for the disease.’’6 In
the current study, an attempt was made to match the
canine population in France by selecting dogs
according to prevalence of the main breeds and by
not taking more than 5 animals from the same
breeder to avoid a ‘‘family’’ effect. There remained 3
biases. The first one is the arbitrary choice to sample
only purebred animals. This was based on the fact
that, to the authors’ knowledge, the proportions and
types of crossbreeds are not reported in the veterinary
literature, thus determining the corresponding refer-
ence sample group was hazardous. Moreover, cross-
breeds reflect the mixing of different breeds, and it
can be expected, but not proven, that values in
crossbreeds fall somewhere within values obtained in
purebred dogs. The second bias is the sex ratio, which
is close to 2 females for 1 male in this sample group.
This results from the authors’ choice to sample dogs
from breeders who have more females than males.
This ratio is much higher than usually reported in the
general canine population, but this should have had
very little influence on the reference intervals as
Harris–Boyd test showed that no partitioning ac-
cording to sex should be applied. The third bias is
Table 2. Descriptive statistics and reference limits of prothrombin time (PT), activated partial thromboplastin time (APTT),
fibrinogen, and antithrombin (AT) in 139 healthy dogs, and characteristics of the distributions.*
PT (sec) APTT (sec) Fibrinogen (g/l) AT (%)
Mean 7.7 15.0 2.26 143
Minimum–Maximum 6.8–9.9 12.8–17.4 1.09–5.18 96–192
Normality, P ,0.0001 5 0.0406 ,0.0001 5 0.58
Best Gaussian fit — Box–Cox . Ln Box–Cox . 1/n Box–Cox
Lower limit of reference interval 6.9 (6.8–7.0) 13.1 (12.8–13.5) 1.24 (1.09–1.43) 104 (96–110)
Upper limit of reference interval 8.8 (8.6–9.9) 17.2 (16.8–17.4) 4.30 (3.85–5.18) 188 (178–192)
* Numbers in parentheses are 90% confidence intervals.
Table 3. Comparison of results obtained with the STA Satellite and the STA-R Evolution analyzers.*
n r a{ b{ Mean bias
PT 57 0.95 1.000 (0.980; 1.064) 0.200 (20.345; 0.378) 0.2 sec
APTT 57 0.84 1.076 (0.969; 1.250) 21.181 (23.875; 0.477) 20.1 sec
Fibrinogen 58 0.93 0.954 (0.918; 1.007) 0.024 (20.125; 0.146) 0.0 g/l
AT 53 0.92 0.780 (0.725; 0.852) 12.540 (5.167; 19.477) 211.8%
* n 5 number of values compared; r 5 Pearson correlation coefficient; PT 5 prothrombin time; APTT 5 activated partial
thromboplastin time; AT 5 antithrombin.
{ Parameters of the following Passing–Bablok equation: STA-R Evolution 5 a 3 STA Satellite + b. Numbers in parentheses indicate
95% confidence intervals.
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because all specimens were collected from breeders
within approximately 200 km of the authors’ labora-
tory, both to ensure the stability of the specimens and
allow rapid analyses on the day of sampling. It is
likely that this ‘‘geographic’’ sampling bias had little
effect on the reference interval results as populations
of dogs have not been reported to differ notably
between different regions of France.
The reference intervals were determined as recom-
mended2 by the nonparametric method. Except for AT,
the distributions were statistically different from Gauss-
ian, which might explain some of the differences with
values previously reported for coagulation tests in dogs,
which were mostly based on parametric approaches.
The transfer of the reference intervals from STA
Satellite to STA-R Evolution is only a palliative
method. It is recommended by IFCC-CLSI when
reference populations can be expected to be identical,
which was the case in the present study. However,
there were some discrepancies in the results obtained
by the 2 analyzers especially for AT, which may lead
to a greater imprecision of the limits thus calculated
for STA-R Evolution.
It has been reported that significant differences in
coagulation test results could be due to the use of
different reagents, especially for APTT. This supports
the claim that each laboratory should determine its
own reference interval for its specific conditions.
However, such determinations are mostly performed
from small samples with unverifiable assumptions
about the underlying distributions. According to
IFCC-CLSI, ‘‘individual laboratories should focus
more on verifying reference interval established
elsewhere.’’2 In the present case, the reference limits
determined in a sufficient number of dogs with the
nonparametric method can be used for validation
studies involving a limited number of specimens, as
indicated by IFCC-CLSI.2
The reference intervals determined in the current
study are similar to previously reported values, except
for AT. This is due to the calibration of the
techniques. In some studies, control dogs were used
to determine the ‘‘normal’’ (i.e., 100%), after which
the measurements were compared with this calibra-
tion, resulting in values centered on 100%. In other
studies, including the present one, calibration was
based on the use of a human calibration solution. The
use of human calibrators has 2 major consequences:
1) it produces a bias, and 2) it probably results in a
better transferability of results, as no canine calibra-
tor is available to the authors’ knowledge, and human
calibrators are readily available and comparable in all
settings.
According to IFCC-CLSI guidelines, the canine
reference intervals determined in the present study
can be used without prior validation by users of these
2 analyzers with the same manufacturer’s reagents,
for animals that fall into the same age range, and
where the proportions of the canine breeds are almost
identical to those in France. In other countries or with
other analyzers or reagents, validation should be
performed.
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